Cargando…

A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1

Synaptic transmission and long-term potentiation (LTP) in the CA1 region of hippocampal slices have been studied during ageing of a double transgenic mouse strain relevant to early-onset familial Alzheimer's disease (AD). This strain, which over-expresses both the 695 amino acid isoform of huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitzjohn, Stephen M, Kuenzi, Frederick, Morton, Robin A, Rosahl, Thomas W, Lewis, Huw, Smith, David, Seabrook, Guy R, Collingridge, Graham L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912307/
https://www.ncbi.nlm.nih.gov/pubmed/20630068
http://dx.doi.org/10.1186/1756-6606-3-21
_version_ 1782184577444347904
author Fitzjohn, Stephen M
Kuenzi, Frederick
Morton, Robin A
Rosahl, Thomas W
Lewis, Huw
Smith, David
Seabrook, Guy R
Collingridge, Graham L
author_facet Fitzjohn, Stephen M
Kuenzi, Frederick
Morton, Robin A
Rosahl, Thomas W
Lewis, Huw
Smith, David
Seabrook, Guy R
Collingridge, Graham L
author_sort Fitzjohn, Stephen M
collection PubMed
description Synaptic transmission and long-term potentiation (LTP) in the CA1 region of hippocampal slices have been studied during ageing of a double transgenic mouse strain relevant to early-onset familial Alzheimer's disease (AD). This strain, which over-expresses both the 695 amino acid isoform of human amyloid precursor protein (APP) with K670N and M671L mutations and presenilin 1 with the A246E mutation, has accelerated amyloidosis and plaque formation. There was a decrease in synaptic transmission in both wildtype and transgenic mice between 2 and 9 months of age. However, preparing slices from 14 month old animals in kynurenic acid (1 mM) counteracted this age-related deficit. Basal transmission and paired-pulse facilitation was similar between the two groups at all ages (2, 6, 9 and 14 months) tested. Similarly, at all ages LTP, induced either by theta burst stimulation or by multiple tetani, was normal. These data show that a prolonged, substantially elevated level of Aβ are not sufficient to cause deficits in the induction or expression of LTP in the CA1 hippocampal region.
format Text
id pubmed-2912307
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29123072010-07-30 A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1 Fitzjohn, Stephen M Kuenzi, Frederick Morton, Robin A Rosahl, Thomas W Lewis, Huw Smith, David Seabrook, Guy R Collingridge, Graham L Mol Brain Research Synaptic transmission and long-term potentiation (LTP) in the CA1 region of hippocampal slices have been studied during ageing of a double transgenic mouse strain relevant to early-onset familial Alzheimer's disease (AD). This strain, which over-expresses both the 695 amino acid isoform of human amyloid precursor protein (APP) with K670N and M671L mutations and presenilin 1 with the A246E mutation, has accelerated amyloidosis and plaque formation. There was a decrease in synaptic transmission in both wildtype and transgenic mice between 2 and 9 months of age. However, preparing slices from 14 month old animals in kynurenic acid (1 mM) counteracted this age-related deficit. Basal transmission and paired-pulse facilitation was similar between the two groups at all ages (2, 6, 9 and 14 months) tested. Similarly, at all ages LTP, induced either by theta burst stimulation or by multiple tetani, was normal. These data show that a prolonged, substantially elevated level of Aβ are not sufficient to cause deficits in the induction or expression of LTP in the CA1 hippocampal region. BioMed Central 2010-07-14 /pmc/articles/PMC2912307/ /pubmed/20630068 http://dx.doi.org/10.1186/1756-6606-3-21 Text en Copyright ©2010 Fitzjohn et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Fitzjohn, Stephen M
Kuenzi, Frederick
Morton, Robin A
Rosahl, Thomas W
Lewis, Huw
Smith, David
Seabrook, Guy R
Collingridge, Graham L
A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1
title A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1
title_full A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1
title_fullStr A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1
title_full_unstemmed A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1
title_short A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1
title_sort study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912307/
https://www.ncbi.nlm.nih.gov/pubmed/20630068
http://dx.doi.org/10.1186/1756-6606-3-21
work_keys_str_mv AT fitzjohnstephenm astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT kuenzifrederick astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT mortonrobina astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT rosahlthomasw astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT lewishuw astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT smithdavid astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT seabrookguyr astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT collingridgegrahaml astudyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT fitzjohnstephenm studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT kuenzifrederick studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT mortonrobina studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT rosahlthomasw studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT lewishuw studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT smithdavid studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT seabrookguyr studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1
AT collingridgegrahaml studyoflongtermpotentiationintransgenicmiceoverexpressingmutantformsofbothamyloidprecursorproteinandpresenilin1